VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 107 filers reported holding VAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,253,571 | -43.9% | 44,205 | -45.1% | 0.00% | – |
| Q2 2023 | $4,019,621 | -44.4% | 80,489 | -58.3% | 0.00% | -100.0% |
| Q1 2023 | $7,230,079 | -53.0% | 192,905 | -39.8% | 0.00% | -50.0% |
| Q4 2022 | $15,370,756 | +359.2% | 320,558 | +129.9% | 0.00% | – |
| Q3 2022 | $3,347,000 | +37.3% | 139,456 | +24.5% | 0.00% | – |
| Q2 2022 | $2,438,000 | +186.2% | 112,031 | +217.7% | 0.00% | – |
| Q1 2022 | $852,000 | -38.4% | 35,260 | -39.3% | 0.00% | – |
| Q4 2021 | $1,382,000 | +103.5% | 58,088 | +117.0% | 0.00% | – |
| Q3 2021 | $679,000 | +59.4% | 26,766 | +41.3% | 0.00% | – |
| Q2 2021 | $426,000 | +29.1% | 18,936 | +13.4% | 0.00% | – |
| Q1 2021 | $330,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management, LLC | 22,227 | $439,000 | 0.50% |